Safety and Performance of DKL Crosslinked Sodium Hyaluronate 26 Dermal Filler for Cheek Augmentation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a pivotal, prospective, active-controlled, randomized, double blinded (blinded evaluator and subject), intra-individual split-face comparison, non-inferiority study of DKL crosslinked sodium hyaluronate 26 versus Juvederm Voluma™ after treatment of subcutaneous to upper-periostea tissue, or deep dermis implantation for cheek augmentation and age-related facial-volume deficit.
Epistemonikos ID: 0d1ed2d88df9ee39d8722353f02c47877cc1b871
First added on: May 09, 2024